Slezska nemocnice v Opave prispevkova organizace
- Address
- lock Available on a paid plan
Slezska nemocnice v Opave - Oncology Research Center
Slezska nemocnice v Opave is a contributing research organization actively engaged in advanced oncology clinical trials, with particular emphasis on prostate cancer therapeutics. The center demonstrates expertise in conducting complex multi-phase studies that evaluate novel treatment approaches for high-risk malignancies.
- High-risk and locally advanced prostate cancer treatment protocols
- Combination therapy studies integrating hormonal agents with radiation therapy
- Metastasis-free survival outcomes in urological oncology
The facility specializes in investigating apalutamide and GnRH agonist combinations alongside primary radiation therapy for patients with localized or locally advanced prostate cancer. Their research infrastructure supports comprehensive efficacy and safety assessments using standardized imaging techniques, positioning them as a valuable contributor to international collaborative oncology trials focused on improving outcomes in patients with very-high risk disease profiles.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Slezska nemocnice v Opave prispevkova organizace
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Phase 3 Randomized, Double-blind, Placebo-controlled Study of Apalutamide and GnRH Agonist in High-risk Localized or Locally Advanced Prostate Cancer with Primary Radiation Therapy | Janssen Cilag International | Phase III | Not Recruiting | Jan 2016 | — |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Apalutamide | 1 | Unknown | 2016-01-27 | 2016-01-27 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.